Lupin Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	500257	NSE Symbol:	LUPIN	P/E :	22.37
ISIN Demat:	INE326A01037	Div & Yield %:	0.61	EPS :	88.38
Book Value:	531.58	Market Cap (Rs. Cr.):	90,285.93	Face Value :	2

Date	Headline
04-Jul-25	Lupin launches Ipratropium Bromide Nasal Solution in US market
01-Jul-25	Lupin receives USFDA approval for Loteprednol Etabonate Ophthalmic Gel
30-Jun-25	Lupin update on transfer of its OTC biz to LUPINLIFE Consumer Healthcare
26-Jun-25	Lupin launches Prucalopride Tablets in US market
25-Jun-25	Lupin receives USFDA approval for Prucalopride Tablets
24-Jun-25	Lupin allots 20,653 equity shares under ESOP
27-May-25	Lupin allots 78,930 equity shares under ESOP
26-May-25	Lupin enters into license and supply agreement with SteinCares
20-May-25	Lupin to develop next-gen inhalers using Honeywell's Solstice® Air propellant
15-May-25	Board of Lupin recommends final dividend

Company Snapshot